Impact drug
A Food and Drug Administration panel unanimously agreed that Biogen and Eisai have proven the efficacy of their Alzheimer’s drug Leqembi, clearing the way for agency approval.
BUSINESS
en-us
2023-06-10T07:00:00.0000000Z
2023-06-10T07:00:00.0000000Z
https://nypost.pressreader.com/article/282123525911857
New York Post